GSK-3β is considered a potential tumor suppressor because it phosphorylates and targets pro-oncogenic molecules, including c-Jun, c-Myc, cyclin D1 and β-catenin, for ubiquitin-dependent proteasomal degradation.7-9. This evidence concerns the gene GSK3B and neoplasm.